SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-013256
Filing Date
2020-07-14
Accepted
2020-07-14 15:55:16
Documents
13
Period of Report
2020-06-04
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 48253
2 ex4-1.htm EX-4.1 82042
3 ex4-2.htm EX-4.2 58987
4 ex10-1.htm EX-10.1 24484
5 ex10-2.htm EX-10.2 58257
6 ex99-1.htm EX-99.1 20773
7 ex4-1_001.jpg GRAPHIC 3292
8 ex4-2_001.jpg GRAPHIC 10913
9 ex10-1_001.jpg GRAPHIC 3897
10 ex10-1_002.jpg GRAPHIC 25551
11 ex10-1_003.jpg GRAPHIC 3268
12 ex99-1_001.jpg GRAPHIC 3524
13 ex99-1_002.jpg GRAPHIC 9913
  Complete submission text file 0001493152-20-013256.txt   378413
Mailing Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022
Business Address 555 MADISON AVENUE 5TH FLOOR SUITE 506 NEW YORK NY 10022 917-796-9926
TAURIGA SCIENCES, INC. (Filer) CIK: 0001142790 (see all company filings)

IRS No.: 651102237 | State of Incorp.: FL | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-53723 | Film No.: 201027188
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences